Johnson & Johnson earns FDA 4-arm robotics clearance
Johnson & Johnson (NYSE:JNJ) secured FDA De Novo authorization for its four-arm OTTAVA robotic surgical system.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Johnson & Johnson (NYSE:JNJ) secured FDA De Novo authorization for its four-arm OTTAVA robotic surgical system.
First BanCorp (NYSE:FBP) reported second-quarter net income of $96.1 million, or $0.62 per share, as lending and interest income increased.
Moody's (NYSE:MCO) reported second-quarter revenue of $2.19 billion alongside an adjusted earnings per share of $4.68.
Stifel Financial (NYSE:SF) reported second-quarter net revenue of $1.45 billion, up 13%, as investment banking and wealth-management revenue increased.
Susan Bell, senior VP of commodity markets, oil at Rystad Energy, says stock levels of refined products are "much more critical" than oil reserves as she examines stockpiles of crude and crude products in the global market.
City Holding Company (NASDAQ:CHCO) reported second-quarter net income of $33.3 million, or $2.35 per diluted share.
Healthcare Services Group (NASDAQ:HCSG) reported second-quarter revenue of $470.8 million to reach a diluted earnings per share of $0.32.
Rogers Communications (NYSE:RCI) reported second-quarter service revenue of $5.1 billion alongside a $4.35 billion cash agreement to acquire the remaining stake in Maple Leaf Sports & Entertainment.
Curis (NASDAQ:CRIS) reported updated clinical data for its emavusertib treatment, demonstrating a 100 percent objective response rate among five evaluable BTK-naïve lymphoma patients as of July 1, 2026.
CME Group (NASDAQ:CME) reported second-quarter revenue of $1.7 billion, driven by market data growth.
Philip Morris International (NYSE:PM) reported second-quarter revenue of $11.2 billion, up 10.4%, as smoke-free and combustible sales increased.
Teledyne Technologies (NYSE:TDY) reported record second-quarter sales of $1.66 billion, up 9.8%, alongside record orders and operating profit.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade